CJC-1295 with DAC – Research Peptide
CJC-1295 with DAC (Drug Affinity Complex) is a synthetic analogue of growth hormone-releasing hormone (GHRH) incorporating a lysine linker attached to a maleimidopropionic acid (MPA) group. This DAC modification enables covalent binding to endogenous albumin, dramatically extending the peptide’s half-life to approximately 6–8 days in circulation.
Research Context
CJC-1295 with DAC activates GHRH receptors on anterior pituitary somatotrophs, stimulating pulsatile GH release and downstream IGF-1 production. Its extended half-life makes it suitable for long-interval dosing research protocols examining sustained GH axis stimulation, lean mass, and metabolic parameters.
Properties
- Class: GHRH analogue with DAC modification
- Form: Lyophilized powder
- Purity: ≥98% (HPLC verified)
- Quantity: 5mg per vial
Storage & Handling
Store at -20°C. Reconstitute with sterile bacteriostatic water. Refrigerate after reconstitution at 2–8°C.
Disclaimer: This product is strictly intended for in vitro laboratory research purposes only. Not for human or veterinary use.
